Difference between revisions of "Part:BBa K590053"
(→‎Usage and Biology)
 
(19 intermediate revisions by the same user not shown)
Line 2: Line 2:
 
<partinfo>BBa_K590053 short</partinfo>
 
<partinfo>BBa_K590053 short</partinfo>
  
−
This part consists of [https://parts.igem.org/wiki/index.php?title=Part:BBa_K590032 Acyl-ACP Reductase], ribosomal binding site , [https://parts.igem.org/Part:BBa_K590031 ''Synechococcus elongatus'' PCC7942 Aldehyde Decarbonylase] under the control of high consititutive promoter for alkane production.  
+
This part consists of [https://parts.igem.org/wiki/index.php?title=Part:BBa_K590032 Acyl-ACP Reductase], ribosomal binding site, [https://parts.igem.org/Part:BBa_K590031 Aldehyde Decarbonylase] under the control of high constitutive promoter for alkane production.  
  
 
===Usage and Biology===
 
===Usage and Biology===
 +
When wild type Aldehyde Decarbonylase is co-expressed with Acyl-ACP Reductase, odd chain length alkanes is produced from the cell's fatty acid biosynthetic pathway. Alkane production is enhanced when growing expression strains using the growth conditions developed by the 2011 University of Washington iGEM Team. For more information, refer to the [http://2011.igem.org/Team:Washington 2011 UW iGEM wiki].
 +
 +
[[Image:Washinton_2011_Optimization_Quant.png|left|450px|thumb|Wild type ADC and AAR are co-expressed and GC-MS quantification of this co-expression shows greater alkane production under optimized conditions.]]
 +
 +
[[Image:Washington_Redesign_Data2.png|right|430px|thumb|Mutant ADCs are co-expressed with AARs under optimized conditions.]]
 +
 +
 +
  
 
<!-- -->
 
<!-- -->

Latest revision as of 19:36, 22 September 2011

RrD_PSB1C3-High constitutive

This part consists of Acyl-ACP Reductase, ribosomal binding site, Aldehyde Decarbonylase under the control of high constitutive promoter for alkane production.

Usage and Biology

When wild type Aldehyde Decarbonylase is co-expressed with Acyl-ACP Reductase, odd chain length alkanes is produced from the cell's fatty acid biosynthetic pathway. Alkane production is enhanced when growing expression strains using the growth conditions developed by the 2011 University of Washington iGEM Team. For more information, refer to the [http://2011.igem.org/Team:Washington 2011 UW iGEM wiki].

Wild type ADC and AAR are co-expressed and GC-MS quantification of this co-expression shows greater alkane production under optimized conditions.
Mutant ADCs are co-expressed with AARs under optimized conditions.



Sequence and Features


Assembly Compatibility:
  • 10
    COMPATIBLE WITH RFC[10]
  • 12
    INCOMPATIBLE WITH RFC[12]
    Illegal NheI site found at 470
    Illegal NheI site found at 493
  • 21
    INCOMPATIBLE WITH RFC[21]
    Illegal XhoI site found at 1584
    Illegal XhoI site found at 2366
  • 23
    COMPATIBLE WITH RFC[23]
  • 25
    INCOMPATIBLE WITH RFC[25]
    Illegal NgoMIV site found at 126
  • 1000
    COMPATIBLE WITH RFC[1000]